Providing next-generation precision delivery platform
Addressing the biggest global unmet clinical needs in tissue regeneration
Renovos offers a step change in tissue repair and therapeutics delivery approaches with an exciting new nanoclay platform
Renovos offers a step change in tissue repair and therapeutics delivery approaches with an exciting new nanoclay platform
The Need for New Approaches
Welcome increase in life expectancy has led to a rise in age-related diseases and healthcare costs. In addition to the ageing world population, increasingly active younger demographics are also prone to trauma, injury or disease. All these result in tissue deterioration for which new regenerative approaches are desperately needed.
Our Mission
We are pioneering a nanoclay gel technology platform, RENOVITE®, for medical applications to address the unmet need for effective long term tissue regeneration, offering safer, more economic clinical solutions for health systems, and better outcomes for patients, to help them remain active for longer.
The Science
Our proprietary platform technology, RENOVITE®, acts as injectable scaffold which attracts regenerative cells and templates new tissue formation. It localises and retains delivered biologics, allowing their use at ultra-low effective doses for safer and more efficient applications in tissue regeneration.
synthetic nanoclay therapeutic delivery platform
Revolutionary platform technology, RENOVITE®, uses synthetic nanoclay to safely and precisely deliver therapeutic agents for regenerative medicine and beyond.
Transforming Patient Lives
Regenerative medicine – the use of new stem cell and material technologies – holds the promise of improving the healing process and therefore relieve pain and return patients to normal life sooner. Renovos aims to help develop and augment treatment plans to repair and replace diseased or damaged tissues to transform lives, for both active living and healthy ageing. We offer a patented carrier and regenerative medicine technology, RENOVITE®, based on nanoclays.
The Need for New Approaches
Welcome increase in life expectancy has led to a rise in age-related diseases and healthcare costs. In addition to the ageing world population, increasingly active younger demographics are also prone to trauma, injury or disease. All these result in tissue deterioration for which new regenerative approaches are desperately needed.
Our Mission
We are pioneering a nanoclay gel technology platform, RENOVITE®, for medical applications to address the unmet need for effective long term tissue regeneration, offering safer, more economic clinical solutions for health systems, and better outcomes for patients, to help them remain active for longer.
The Science
Our proprietary platform technology, RENOVITE®, acts as injectable scaffold which attracts regenerative cells and templates new tissue formation. It localises and retains delivered biologics, allowing their use at ultra-low effective doses for safer and more efficient applications in tissue regeneration.
synthetic nanoclay therapeutic delivery platform
Transforming Patient Lives
Partnering Opportunities
Our RENOVITE® nanoclay technology has been refined and developed over years of academic research, innovation, rigorous testing and validation.
Renovos welcomes enquiries from potential partners that might wish to utilise our RENOVITE® nanoclay in their own therapeutics, biologics or device development programmes or those with an interest in partnering in one of Renovos’ in-house developments.
